| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |